Gene · 3860
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fused Enzyme Glucose-6-Phosphate Dehydrogenase::6-Phosphogluconolactonase (G6PD::6PGL) as a Potential Drug Target in Giardia lamblia, Trichomonas vaginalis, and Plasmodium falciparum. | Microorganisms | 2024 | 38257939 | PubTator, text mining | PubMed |
| Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential. | Int J Mol Sci | 2024 | 38255791 | PubTator, text mining | PubMed |
| Multi-omic analyses of m5C readers reveal their characteristics and immunotherapeutic proficiency. | Sci Rep | 2024 | 38238581 | PubTator, text mining | PubMed |
| Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection. | PLoS Pathog | 2024 | 38232124 | PubTator, text mining | PubMed |
| SOX4 reversibly induces phenotypic changes by suppressing the epithelial marker genes in human keratinocytes. | Mol Biol Rep | 2024 | 38227121 | PubTator, text mining | PubMed |
| Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer. | Int J Gen Med | 2024 | 38221941 | PubTator, text mining | PubMed |
| HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation. | Heliyon | 2024 | 38192826 | PubTator, text mining | PubMed |
| Diagnosis of differentiated dysplasia as a variant of oral epithelial dysplasia. | Oral Dis | 2024 | 38191851 | PubTator, text mining | PubMed |
| In vitro delayed response to dihydroartemisinin of malaria parasites infecting sickle cell erythocytes. | Malar J | 2024 | 38178227 | PubTator, text mining | PubMed |
| Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p. | Theranostics | 2024 | 38169528 | PubTator, text mining | PubMed |
| Escalating Plasmodium falciparum K13 marker prevalence indicative of artemisinin resistance in southern Rwanda. | Antimicrob Agents Chemother | 2024 | 38092677 | PubTator, text mining | PubMed |
| Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo. | Int J Infect Dis | 2024 | 38016502 | PubTator, text mining | PubMed |
A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda. | Gates Open Res | 2023 | 38196920 | PubTator, text mining | PubMed |
| Focus on limbal stem cell deficiency and limbal cell transplantation. | World J Transplant | 2023 | 38174150 | PubTator, text mining | PubMed |
| Induction of Artesunate Resistance in Plasmodium falciparum 3D7 Strain Using Intermittent Exposure Method and Comparing P.fk13 Sequence between Susceptible and Resistant Strains. | Iran J Parasitol | 2023 | 38169593 | PubTator, text mining | PubMed |
| Current Perspectives on Paradental Cyst: A Literature Review. | Dent J (Basel) | 2023 | 38132419 | PubTator, text mining | PubMed |
| Immunohistochemistry in an Adult Case of Bitot's Spots Caused by Vitamin A Deficiency. | Diagnostics (Basel) | 2023 | 38132260 | PubTator, text mining | PubMed |
| KRT13 and UPK1B for differential diagnosis between metastatic lung carcinoma from oral squamous cell carcinoma and lung squamous cell carcinoma. | Sci Rep | 2023 | 38114532 | PubTator, text mining | PubMed |
| Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated Plasmodium falciparum infection. | J Travel Med | 2023 | 38109778 | PubTator, text mining | PubMed |
| A New Era of Integration between Multiomics and Spatio-Temporal Analysis for the Translation of EMT towards Clinical Applications in Cancer. | Cells | 2023 | 38067168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3860/papers?page=8